Sign In
Buy JAN
$27.04
+0.730 (+2.77%)
At Close: Jun 23, 2026
JanOne Enters Option Agreement For Rights To Novel Strategy To Reduce Methamphetamine Use
03:26pm, Tuesday, 07'th Dec 2021
JanOne Inc (NASDAQ: JAN) has acquired an option agreement for the rights to a novel strategy to reduce methamphetamine (meth) use by activating the Translocator Protein 18 kDa (TSPO). The agreeme
Goldfarb Andrew P Buys JanOne Inc
08:38pm, Monday, 15'th Nov 2021 GuruFocus
Related Stocks: JAN ,
MINNEAPOLIS, Oct. 19, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), has seen major growth in its appliance replacement programs throughout the pa
ARCA Recycling, a Subsidiary of JanOne Inc., Opens New Pennsauken, NJ, Recycling Center, Launches New Recycling Programs
09:00am, Thursday, 30'th Sep 2021
MINNEAPOLIS, Sept. 30, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), opened a new appliance recycling center last month in Pennsauken, New Jersey.
JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101
04:05pm, Tuesday, 28'th Sep 2021
LAS VEGAS, Sept. 28, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of treatments for conditions that cause severe pain – in conjunction with its continui
JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients
09:45am, Thursday, 22'nd Jul 2021
LAS VEGAS, July 22, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving proper
JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites
10:10am, Wednesday, 23'rd Jun 2021
LAS VEGAS, June 23, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving prope
JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board
10:15am, Tuesday, 15'th Jun 2021
LAS VEGAS, June 15, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving proper
JanOne Engages DC Consulting LLC for Government and Private Sector Initiatives
10:15am, Thursday, 10'th Jun 2021
LAS VEGAS, June 10, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving prope
JanOne Announces Closing of $6.0 Million Common Stock Offering
11:45am, Tuesday, 02'nd Feb 2021
LAS VEGAS, Feb. 2, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving propert
JanOne Prices $6.0 Million Common Stock Offering
08:45am, Friday, 29'th Jan 2021
LAS VEGAS, Jan. 29, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving proper
JAN Stock: JanOne Shares Skyrocket as Part of Reddit Run-Up Fever
10:09am, Thursday, 28'th Jan 2021
JanOne (JAN) stock is soaring higher Thursday morning as it joins other stocks being boosted by Reddit and other social media users. The post JAN Stock: JanOne Shares Skyrocket as Part of Reddit Run-U
JAN Stock Price Increases Over 198% Pre-Market: Why It Happened
08:26am, Thursday, 28'th Jan 2021
The stock price of Janone Inc (NASDAQ: JAN) has increased over 190% pre-market today. This is why it happened.
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript
09:38pm, Tuesday, 25'th Aug 2020
JanOne Inc. (NASDAQ:JAN) Telebriefing and Corporate Update Call August 25, 2020 16:15 ET Corporate Participants Tony Isaac - Chief Executive Officer Tony Giordano - Chief Scientific Officer Amol Soin
JanOne to Present at The LD 500 Virtual Conference
06:50pm, Wednesday, 19'th Aug 2020
JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced that it w
